RxDoctor Payments Data

Smith Joseph, DO

Internal Medicine · North Miami, FLNPI 1851376552

Payments from drug & device makers

$235in general payments, 2019–2025

Across 11 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$59
  • Exact Sciences$48
  • Pfizer$34
  • Boehringer Ingelheim$21
  • GSK$20
  • Johnson & Johnson$20
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$235100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$235 in reported general payments places this provider in the 40th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$3,897
Medicare patients
13
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin117$176,229
JanuviaSitagliptin Phosphate43$66,786
JulucaDolutegravir/Rilpivirine12$39,618
TriumeqAbacavir/Dolutegravir/Lamivudi12$37,548
EliquisApixaban22$33,425
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$6,043
Nifedipine ErNifedipine184$4,106
Glipizide-MetforminGlipizide/Metformin Hcl33$2,988
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide110$2,840
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm22$2,727
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm20$2,547
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide181$2,217
Atorvastatin Calcium278$2,194
Albuterol Sulfate HfaAlbuterol Sulfate43$1,943
Glipizide ErGlipizide71$1,722

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$21$176,229117 claims
PfizerEliquis$34$33,42522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in North Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →